Why A 'White Knight' Could Still Fight For Day One Bio - Investor's Business Daily
Source:Investor's Business Daily
The deal will expand Servier’s pipeline of cancer treatments. But an analyst says other companies could make overtures.
The deal will expand Servier’s pipeline of cancer treatments. But an analyst says other companies could make overtures.